Steven LaRosa

Corporate Officer/Principal bei AETHLON MEDICAL, INC.

Vermögen: - $ am 31.05.2024

57 Jahre

Health Technology

Consumer Services

Health Services

Aktive Positionen von Steven LaRosa

Unternehmen	Position	Beginn	Ende
AETHLON MEDICAL, INC.	Corporate Officer/Principal	06.01.2021	-
Beth Israel Lahey Health, Inc. Beth Israel Lahey Health, Inc. Medical/Nursing ServicesHealth Services Beth Israel Lahey Health, Inc. is a non-profir organization provides healthcare services. The company is headquartered in Cambridge, MA.	Corporate Officer/Principal	-	-

Unternehmen	Position	Beginn	Ende
Entasis Therapeutics, Inc. Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA.	Corporate Officer/Principal	01.03.2020	01.12.2020
Northeast Hospital Corp.	Corporate Officer/Principal	-	-

Boston College	Undergraduate Degree
Boston University School of Medicine	Doctorate Degree

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	4
Doctorate Degree	1
Undergraduate Degree	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
AETHLON MEDICAL, INC.	Health Technology

Private Unternehmen	3
Northeast Hospital Corp.
Entasis Therapeutics, Inc. Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA.	Health Technology
Beth Israel Lahey Health, Inc. Beth Israel Lahey Health, Inc. Medical/Nursing ServicesHealth Services Beth Israel Lahey Health, Inc. is a non-profir organization provides healthcare services. The company is headquartered in Cambridge, MA.	Health Services